Evidence map›Paper›PMID 40937366›Full record

ArticleSchizophrenia research. Cognition2025

Equivalence verification of the electronic version of the Chinese Brief Cognitive Test (C-BCT): Focus on Chinese schizophrenia populations.

Han Han, Shuling Ye, Mengjuan Xie, Xin Yu, Renrong Wu, Dengtang Liu, Shaohua Hu, Yong Xu, Huanzhong Liu, Xijin Wang and 11 more

Abstract read
In one paragraph

Article in Schizophrenia research. Cognition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Han HanBeijing Huilongguan Hospital, Peking University Huilongguan Clinical Medical School, Beijing 100096, China.
Shuling YePeking University Institute of Mental Health (Sixth Hospital), Beijing 100191, China.
Mengjuan XieThe Eighth People's Hospital of Zhengzhou, Zhengzhou 450006, China.
Xin YuPeking University Institute of Mental Health (Sixth Hospital), Beijing 100191, China.
Renrong WuDepartment of Psychiatry, Institute of Mental Health of Second Xiangya Hospital, Central South University,Changsha, Hunan 410011, China.
Dengtang LiuDivision of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
Shaohua HuDepartment of Psychiatry, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Yong XuDepartment of Psychiatry, First Clinical Medical College/First Hospital of Shanxi Medical University, Taiyuan 030012, China.
Huanzhong LiuDepartment of Psychiatry, Chaohu Hospital, Anhui Medical University, Hefei 238000, China.
Xijin WangThe First Psychiatric Hospital of Harbin, Harbin, Heilongjiang 150000, China.
Gang ZhuDepartment of Psychiatry, the First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Huaning WangDepartment of Psychiatry, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Shaohong ZouDepartment of Clinical Psychology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China.
Tao LiAffiliated Mental Health Center and Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou 830001, China.
Wanjun GuoThe Mental Health Center, Sichuan University, Chengdu 610041, China.
Xiufeng XuDepartment of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Yuqi ChengDepartment of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Yi LiWuhan Mental Health Center, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430012, China.
Juan YangDepartment of Psychology, Hainan Medical University, Haikou 571199, China.
Min PengHuazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518052, China.
Chuan ShiPeking University Institute of Mental Health (Sixth Hospital), Beijing 100191, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To complete the preparation of the electronic version of C-BCT, verifying the criterion validity of the electronic version of C-BCT. Methods: 747 healthy subjects and 139 schizophrenics completed the electronic version of C-BCT and MCCB. To measure psychotic symptoms and severity, patients with schizophrenia completed the PANSS scale. Mean, standard deviation, percentage, etc. were used to describe demographic variables. One-way analysis of variance and independent sample Results: In the equivalence analysis of the healthy group, all tests have good calibration validity ( Conclusion: The electronic version of C-BCT has been compiled. The electronic version of the C-BCT performs well in overall calibration validity and could be used to assess the cognitive function of schizophrenia.

Indexed as

Calibration validityC-BCTCognitive impairmentMCCBSchizophrenia

Identifiers

PMID40937366
PMCPMC12421633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.